¹⁷⁷Lu-Labeled Eu-Doped Mesoporous SiO₂Nanoparticles as a Theranostic Radiopharmaceutical for Colorectal Cancer

Keyphrases

• Colorectal Cancer 100%
• Silica 100%
• Mesoporous 100%
• SiO2 Nanoparticles 100%
• Eu Doping 100%
• Theranostic Radiopharmaceuticals 100%
• Lutetium-177 (177Lu) 100%
• Nanoparticles 72%
• Eu3+ 18%
• SPECT Imaging 18%
• HT-29 18%
• Radioactivity 18%
• Nanomaterials 18%
• Mouse Model 9%
• Tumor Growth 9%
• Disease Progression 9%
• Disease Stage 9%
• Effective Treatment 9%
• Further Development 9%
• Fluorescence Microscopy 9%
• Cellular Uptake 9%
• Therapeutic Potential 9%
• Nanotechnology 9%
• Fourier Transform Infrared Spectroscopy (FT-IR) 9%
• Image Analysis 9%
• SPECT-CT 9%
• Luminescence 9%
• Cancer Types 9%
• Clinical Treatment 9%
• Radiotherapy 9%
• Intratumoral Injection 9%
• Intratumoral Administration 9%
• Tumor Localization 9%
• HT-29 Xenograft 9%
• Mortality Cases 9%
• Radionuclides 9%
• Dual-modality Probe 9%
• Amino-functionalized Mesoporous Silica 9%
• Coordination Complex 9%
• 6-dicarboxylic Acid 9%
• Tumor Radiotherapy 9%
• Lanthanide Ions 9%
• Pyrimidine-2 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Silicon Dioxide 100%
• Radiopharmaceutical Agent 100%
• Lutetium 177 100%
• Colorectal Carcinoma 100%
• Nanoparticle 72%
• Neoplasm 18%
• Nanomaterial 18%
• Mouse Model 9%
• Malignant Neoplasm 9%
• Tumor Growth 9%
• Scanning Electron Microscopy 9%
• Disease Exacerbation 9%
• Tracer 9%
• Fluorescence Microscopy 9%
• Mesoporous Silica 9%
• Lanthanide 9%
• Radioisotope 9%
• Coordination Compound 9%
• Dicarboxylic Acid 9%

Material Science

• Nanoparticle 100%
• Tumor 37%
• Nanostructured Material 25%
• Luminescence 12%
• Thermogravimetric Analysis 12%
• Lanthanide Series 12%
• Fluorescence Microscopy 12%
• Coordination Compound 12%
• Scanning Electron Microscopy 12%
• Mesoporous Silica 12%
• Phase Composition 12%